Laparoscopic Anatomic vs. Nonanatomic Liver Resection for Large Hepatocellular Carcinoma (≥5 cm) in the Right Lobe

医学 肝细胞癌 切除缘 倾向得分匹配 外科 入射(几何) 切除术 肝切除术 波瓣 腹腔镜检查 内科学 病理 光学 物理
作者
ahmed badawy,Ho‐Seong Han,Tamer M. Elmahdy,Hossam Eldeen M. Soliman,Mohammad Hamdy Abo‐Ryia,Osama Helmy El-Khadrawy
出处
期刊:Hpb [Elsevier BV]
标识
DOI:10.1016/j.hpb.2024.01.005
摘要

Objective To determine the impacts and outcomes of laparoscopic anatomic liver resection (LAR) and laparoscopic nonanatomic resection (LNAR) in patients with large hepatocellular carcinoma (HCC) in the right lobe of the liver. Background There are few comparative studies of LAR and LNAR for large HCC. Method Three hundred thirty-seven patients underwent liver resection for large HCC (≥5 cm) at Seoul National University Bundang Hospital, Seoul, Korea, between January 2004 and December 2022. After the exclusion of patients treated with open hepatic resection and those who had left-lobe or bilobar tumors, 94 patients were ultimately included. Patients were divided into LAR group (61 patients) and LNAR group (33 patients). After propensity score matching (PSM) with 1:1 matching, 31 patients were included in each group. The outcomes in the two groups were compared. Results LAR group had longer operative time than LNAR group (333.7 ± 113.7 vs 210 ± 117.6 min, respectively, P < 0.001), wider safety margin (1.4 ± 1.5 vs 0.7 ± 0.7 cm, respectively, P = 0.015), and lower incidence of recurrence (25.8% vs. 54.8%, respectively, P = 0.021). Conclusion LAR required longer operative time, achieved wider safety margin, and had lower incidence of recurrence than LNAR. To determine the impacts and outcomes of laparoscopic anatomic liver resection (LAR) and laparoscopic nonanatomic resection (LNAR) in patients with large hepatocellular carcinoma (HCC) in the right lobe of the liver. There are few comparative studies of LAR and LNAR for large HCC. Three hundred thirty-seven patients underwent liver resection for large HCC (≥5 cm) at Seoul National University Bundang Hospital, Seoul, Korea, between January 2004 and December 2022. After the exclusion of patients treated with open hepatic resection and those who had left-lobe or bilobar tumors, 94 patients were ultimately included. Patients were divided into LAR group (61 patients) and LNAR group (33 patients). After propensity score matching (PSM) with 1:1 matching, 31 patients were included in each group. The outcomes in the two groups were compared. LAR group had longer operative time than LNAR group (333.7 ± 113.7 vs 210 ± 117.6 min, respectively, P < 0.001), wider safety margin (1.4 ± 1.5 vs 0.7 ± 0.7 cm, respectively, P = 0.015), and lower incidence of recurrence (25.8% vs. 54.8%, respectively, P = 0.021). LAR required longer operative time, achieved wider safety margin, and had lower incidence of recurrence than LNAR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
我是老大应助科研通管家采纳,获得50
刚刚
我是老大应助科研通管家采纳,获得50
刚刚
asdfzxcv应助科研通管家采纳,获得30
刚刚
asdfzxcv应助科研通管家采纳,获得30
刚刚
刚刚
淡淡的发卡完成签到,获得积分0
刚刚
刚刚
小马甲应助科研通管家采纳,获得10
1秒前
小马甲应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
lyd完成签到,获得积分10
1秒前
无语的白昼关注了科研通微信公众号
1秒前
1秒前
只争朝夕应助科研通管家采纳,获得10
1秒前
只争朝夕应助科研通管家采纳,获得10
1秒前
在水一方应助科研通管家采纳,获得10
1秒前
在水一方应助科研通管家采纳,获得10
1秒前
大模型应助科研通管家采纳,获得30
1秒前
大模型应助科研通管家采纳,获得30
1秒前
CodeCraft应助科研通管家采纳,获得30
1秒前
深情安青应助zhangdamiao采纳,获得10
1秒前
科研通AI6.1应助Xyy采纳,获得10
2秒前
暗黑同学完成签到,获得积分0
2秒前
木木发布了新的文献求助10
2秒前
CodeCraft应助科研通管家采纳,获得30
2秒前
1nidaye发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
英姑应助科研通管家采纳,获得10
2秒前
英姑应助科研通管家采纳,获得10
2秒前
2秒前
3秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Feldspar inclusion dating of ceramics and burnt stones 1000
What is the Future of Psychotherapy in a Digital Age? 801
The Psychological Quest for Meaning 800
Digital and Social Media Marketing 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5981827
求助须知:如何正确求助?哪些是违规求助? 7373249
关于积分的说明 16025833
捐赠科研通 5121999
什么是DOI,文献DOI怎么找? 2748804
邀请新用户注册赠送积分活动 1718712
关于科研通互助平台的介绍 1625335